Comparing Brief Relaxation Period to Virtual Reality Period in Reducing Dental Anxiety Prior to Root Canal Treatment

Sponsor
Indiana University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05720897
Collaborator
(none)
60
1
2
3
20.3

Study Details

Study Description

Brief Summary

The goal of this study is to evaluate non-drug approaches to reducing dental anxiety prior to non-surgical root canal treatment. This will be done by comparing two relaxation methods which will be performed immediately prior to scheduled, clinical non-surgical root canal treatment. Measures of anxiety will be evaluated prior to, and after, the relaxation intervention, as well as after the non-surgical root canal treatment is completed. Participation in the study is completed in a single study visit.

Condition or Disease Intervention/Treatment Phase
  • Other: Auditory Alone
  • Device: Relaxation Virtual Reality
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparing Brief Relaxation Period to Virtual Reality Period in Reducing Dental Anxiety Prior to Root Canal Treatment; a Randomized Control Trial
Actual Study Start Date :
Jan 11, 2023
Anticipated Primary Completion Date :
Apr 11, 2023
Anticipated Study Completion Date :
Apr 11, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Auditory Alone Brief Relaxation

Participants randomized to this arm will receive earphones to listen to a guided brief relaxation recording, focusing on breathing and a body scan, prior to their dental procedure.

Other: Auditory Alone
Participants randomized to this arm will receive earphones to listen to an 8 minute guided brief relaxation recording, focusing on breathing and a body scan. Participants will listen to the recording prior to their dental procedure.
Other Names:
  • ABR
  • Experimental: Relaxation Virtual Reality

    Participants will receive virtual reality goggles and choose a scene of their liking to experience, prior to their dental procedure.

    Device: Relaxation Virtual Reality
    Participants randomized to this arm will receive will receive virtual reality goggles and choose a scene of their liking to experience. Participants will choose from 11 different themed environments (such as savannah, beach, meadow, or space), and will experience the chosen virtual reality environment for 8 minutes. Participants will complete the virtual reality intervention prior to their dental procedure.
    Other Names:
  • RVR
  • Outcome Measures

    Primary Outcome Measures

    1. Mean Change from baseline in State-Trait Anxiety Indicator (STAI) Score at the end of the study visit [From enrollment to the end of the dental visit, approximately 90 minutes]

      STAI is a 40 item questionnaire which measures subjective self-reported feelings of dental anxiety. Responses for each item include four possible responses that range from "very much" to "not at all" and which correlate to a numerical value. A score of 45-80 indicate "high anxiety": 38-44 indicate "moderate anxiety": 20-37 indicate low or no anxiety. During the single study visit, participants will complete the STAI twice: at enrollment (prior to undergoing the randomly assigned relaxation intervention) and again at the end of the visit.

    2. Mean Change from baseline in anxiety as rated on a Visual Analog Score (VAS) at the end of the relaxation intervention [From enrollment to the end of the relaxation intervention, approximately 10 minutes]

      The VAS will be a single question in which the participant is asked to assign and report a numerical value to the amount of anxiety one is feeling in the moment. It consists of a 10 point scale, with one symbolizing no anxiety and 10 symbolizing unbearable anxiety. During the single study visit, participants will complete the VAS three times: at enrollment (prior to the assigned relaxation intervention), at the end of the relaxation intervention, and at the end of the study visit.

    3. Mean Change from baseline in anxiety as rated on a Visual Analog Score (VAS) at the end of the study visit [From enrollment to the end of the dental visit, approximately 90 minutes]

      The VAS will be a single question in which the participant is asked to assign and report a numerical value to the amount of anxiety one is feeling in the moment. It consists of a 10 point scale, with one symbolizing no anxiety and 10 symbolizing unbearable anxiety. During the single study visit, participants will complete the VAS three times: at enrollment (prior to the assigned relaxation intervention), at the end of the relaxation intervention, and at the end of the study visit.

    4. Mean Change from baseline in blood pressure (BP) at the end of the relaxation intervention [From enrollment to the end of the relaxation intervention, approximately 10 minutes]

      BP will be measured three times during the single study visit: at enrollment (prior to the assigned relaxation intervention), at the end of the assigned relaxation intervention, and at the end of the visit.

    5. Mean Change from baseline in blood pressure (BP) at the end of the study visit [From enrollment to the end of the dental visit, approximately 90 minutes]

      BP will be measured three times during the single study visit: at enrollment (prior to the assigned relaxation intervention), at the end of the assigned relaxation intervention, and at the end of the visit.

    6. Mean Change from baseline in heart rate (HR) to the end of the relaxation intervention [From enrollment to the end of the relaxation intervention, approximately 10 minutes]

      HR will be measured three times during the single study visit: at enrollment (prior to the assigned relaxation intervention), at the end of the assigned relaxation intervention, and at the end of the study visit.

    7. Mean Change from baseline in heart rate (HR) at the end of the study visit [From enrollment to the end of the dental visit, approximately 90 minutes]

      HR will be measured three times during the single study visit: at enrollment (prior to the assigned relaxation intervention), at the end of the assigned relaxation intervention, and at the end of the study visit.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • requires non-surgical root canal treatment

    • is able to independently provide informed consent for root canal treatment

    • proficient in English

    Exclusion Criteria:
    • history of vertigo or severe motion sickness

    • history of severe psychiatric disease

    • history of seizures, concussions, or severe neurological conditions

    • visual or hearing impairments

    • cardiac pacemaker or defibrillator

    • will require nitrous oxide sedation, nor pharmacologic anxiolytics or sedatives for dental treatment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Indiana University, School of Dentistry Indianapolis Indiana United States 46202

    Sponsors and Collaborators

    • Indiana University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Stuart Schrader, Clinical Associate Professor, Indiana University
    ClinicalTrials.gov Identifier:
    NCT05720897
    Other Study ID Numbers:
    • IRB # 17053
    First Posted:
    Feb 9, 2023
    Last Update Posted:
    Feb 9, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 9, 2023